Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine
Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Location: United States, KY

Clinical Trial Details

Overview

Research Study Summary

COPD Chronic

Purpose

Purpose:

This study evaluates the long-term safety of Roflumilast in patients with chronic COPD. The medication is already available and on the market today.

Duration:

52 Weeks

Visits:

9 Visits

Compensation:

$100 per visit for visits 1-8 and $50 for visit 9 and $15 for unscheduled visits. You may be reimbursed up to $25

Criteria:

Males and Females over the age 40 with a diagnosis of moderate or severe COPD. Other criteria may apply.

To Learn more
Gender

Both Male and Female

Age

40 and up

Overall Status

Recruiting

Duration

52 Weeks

Facility Type

N/A

Compensation

$100 to $850

Contact

Kentucky Medical Research
354 Waller Avenue, Suite 110
Lexington, KY 40504
Phone: 859-225-5672
Fax: 859-276-1020

View Map

Research Center Information: Kentucky Medical Research

CW ID: 183341

Date Last Changed: July 16, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.